Clinical Trial Update: Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS] [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating tamoxifen therapy for amyotrophic lateral sclerosis has completed. The snippet does not include the trial outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: COMPLETED